Coca-Cola Europacific Partners PLC Q1 FY26 Earnings Analysis
Published 29 May 2026 | Beverages | Market Cap: ₹41.9K Cr
Price
₹92.29
Market Cap
₹41.9K Cr
P/E Ratio
18.8
Revenue Rank
Margin Rank
Earnings Summary
- **Overall growth outlook**: Expecting 3-4% revenue growth in 2026 driven by volume and revenue per unit case, reflecting a slightly below midterm top line target due to Suntory exit impact. - Operating profit expected to be fairly balanced between H1 and H2 of 2026 despite extra days in H1 and Suntory exit impact (Page 14).
📊 Revenue & Sales Performance
Rank 4- **Overall growth outlook**: Expecting 3-4% revenue growth in 2026 driven by volume and revenue per unit case, reflecting a slightly below midterm top line target due to Suntory exit impact. - **Operating profit**: Guidance for consistent 7% operating profit growth aligned with midterm algorithm despite top line challenges, leveraging strong revenue per case, favorable COGS, and cost savings. - **Volume impact**: Anticipate more revenue growth from volume in 2026 compared to 2025; volume growth remains important though pushes slightly less profit than pricing/mix. - **Indonesia**: Plan for volume growth in 2026 after previous double-digit declines, expecting a single-digit volume turnaround fueling future growth potential. - **Energy category**: Continue robust growth at mid-teens volume increase, driven by strong innovation pipeline, increased distribution, and expansion of Zero products. - **Europe channels**: Continued momentum expected in away-from-home channel driven by strategic investment and execution. - **Growth management**: Significant further potential in revenue growth management via pricing, pack innovation, and smarter promotional spending.
📈 Profitability & Margins
Rank 3- Operating profit expected to be fairly balanced between H1 and H2 of 2026 despite extra days in H1 and Suntory exit impact (Page 14). - Guidance for 2026 indicates a 7% operating profit growth in line with mid-term targets, despite slightly below mid-term top-line expectations (Page 12). - Drivers for consistent operating profit growth include strong revenue per case drop-through, favorable COGS environment, and ongoing cost savings/productivity improvements (Page 12). - Positive mix effects from category, channel, packaging, and price promotions are expected to support profitability (Page 14). - Earnings per share (EPS) grew by 6.2% in 2025, supported by share buybacks; a growing dividend and further €1 billion buybacks planned for 2026 indicate confidence in sustained earnings growth (Pages 3, 6). - Revenue growth and margin management remain key focus areas, supported by innovation and pricing strategies (Pages 10, 14).
🏗️ Capital Expenditure Plans
Yes- Over EUR 1 billion CapEx planned for 2026, consistent with prior year investments. - Key projects include: - New aseptic capabilities. - New canning line at Queensland site. - Construction of a new plant outside Manila (largest infrastructure investment to date). - New ARTD (alcohol-related) capacity. - More coolers for retail activation. - Continued development of digital, AI, and SAP S/4HANA systems. - Investments aimed at driving top-line growth, productivity, and operating margin expansion. - Focus on expanding digital and AI capabilities to optimize promo spend, demand forecasting, and operations. - New Manila shared services center opened to centralize activities and enhance efficiency. - Transformation initiatives in Indonesia with reduced production sites and optimized logistics via third-party partnerships.
💰 Fundraising & Capital Structure
No information- No explicit mention of new fundraising through equity or debt in the provided pages. - The company aims to maintain an investment-grade rating with leverage targeted between 2.5x to 3x net debt-to-EBITDA. - They currently have strong access to borrowing at competitive rates in the current interest rate environment. - They expect a modest increase in annual interest expense due to refinancing approximately EUR 1 billion per year, linked to prior acquisition financing. - Capital allocation priorities remain unchanged, focusing on maintaining a strong and flexible balance sheet. - They continue to invest over EUR 1 billion in CapEx annually, with no specific mention of needing additional external fundraising. - The company is open to value-accretive M&A but no current active plans specified.
📋 Order Book & Pipeline
No informationThe provided pages of the PDF do not contain any specific information regarding the current or expected orderbook or pending orders. The discussion mainly focuses on: - Operating profit expectations and balancing between H1 and H2. - Margin expansion and productivity improvements in various markets including the Philippines and Indonesia. - Growth projections in categories such as energy and sparkling beverages. - Investments in shared service centers, technology, AI, and supply chain improvements. - Capital allocation, leverage, and shareholder returns. - Market-specific performance and innovation plans. No direct data or commentary on orderbook status or pending orders is mentioned in the excerpted text.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Coca-Cola Europacific Partners PLC Q1 FY26 results?
- **Overall growth outlook**: Expecting 3-4% revenue growth in 2026 driven by volume and revenue per unit case, reflecting a slightly below midterm top line target due to Suntory exit impact. - Operating profit expected to be fairly balanced between H1 and H2 of 2026 despite extra days in H1 and Suntory exit impact (Page 14).
What is Coca-Cola Europacific Partners PLC share price analysis?
Coca-Cola Europacific Partners PLC currently shows a neutral. The stock trades at a P/E of 18.8 with a market cap of $41,898. Investors should review the full earnings analysis for detailed insights.
Is Coca-Cola Europacific Partners PLC planning capital expenditure?
- Over EUR 1 billion CapEx planned for 2026, consistent with prior year investments.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
